Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report
1996

CHART vs Conventional Radiotherapy in Cancer Treatment

Sample size: 1481 publication Evidence: moderate

Author Information

Author(s): MI Saunders, S Dischel, A Barrett, MKB Parmar, A Harvey, D Gibson

Primary Institution: Marie Curie Research Wing for Oncology, Centre for Cancer Treatment, Mount Vernon Hospital

Hypothesis

Cellular repopulation is important as a cause of failure in radiotherapy.

Conclusion

The CHART regimen showed improved survival in non-small-cell lung cancer patients compared to conventional treatment.

Supporting Evidence

  • 30% of CHART patients were alive at 2 years compared to 20% in the control group.
  • CHART showed a trend for improved local tumor control with increasing tumor stage.
  • Early reactions were more severe with CHART but subsided quickly.

Takeaway

This study tested a new way to give radiation therapy that takes less time and found it helps some cancer patients live longer.

Methodology

The study compared CHART with conventional radiotherapy in a randomized controlled trial involving patients with head and neck cancer and non-small-cell lung cancer.

Limitations

The study is an interim report and further analysis is needed as data mature.

Participant Demographics

Patients included were over 18 years old with head and neck cancer or non-small-cell lung cancer.

Statistical Information

P-Value

0.006

Confidence Interval

0.61-0.93

Statistical Significance

p=0.006

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication